QQQ ETF Climbs 2.9%, Outperforms Underlying Index
Dow Jones2026/09/21 20:36This article was automatically generated using Dow Jones technology.
Shares of Invesco QQQ Trust Series I advanced 2.9% to $741.47 Monday on what proved to be an overall favorable trading session for the U.S. stock market, with the S&P 500 Index rising 1.5% to 7,764.70.
This was the fund's fourth consecutive day of gains. The fund's underlying index, the NASDAQ 100 Index (NASDAQ Calculation), rose 2.8%.
The ETF's shares closed 1.0% below the 52-week high of $748.65 seen on June 3, 2026.
Trading volume was 46,186,389, compared to the 65-day average trading volume of 37,618,074.
As of September 18, the fund's net asset value totaled $721.72 per share.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 21, 2026 16:36 ET (20:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Crypto prices
More
